Targeting SPOP with small molecules provides a novel strategy for kidney cancer therapy

scientific article published on 23 November 2016

Targeting SPOP with small molecules provides a novel strategy for kidney cancer therapy is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S11427-016-0297-2
P698PubMed publication ID27888385

P2093author name stringCai-Guang Yang
Tong Zheng
P2860cites workEvolving Immunotherapy Approaches for Renal Cell Carcinoma.Q38913703
Small-Molecule Targeting of E3 Ligase Adaptor SPOP in Kidney CancerQ51513706
Adaptor protein self-assembly drives the control of a cullin-RING ubiquitin ligaseQ24336527
SPOP promotes tumorigenesis by acting as a key regulatory hub in kidney cancerQ24339492
Structures of SPOP-Substrate Complexes: Insights into Molecular Architectures of BTB-Cul3 Ubiquitin LigasesQ27657740
On-target efficacy of a HIF-2α antagonist in preclinical kidney cancer modelsQ27727998
Analysis of Drosophila segmentation network identifies a JNK pathway factor overexpressed in kidney cancer.Q37373844
Targeting renal cell carcinoma with a HIF-2 antagonist.Q37684974
P433issue1
P921main subjectkidney cancerQ3242950
P304page(s)91-93
P577publication date2016-11-23
P1433published inScience in China. Series C: Life SciencesQ2619480
P1476titleTargeting SPOP with small molecules provides a novel strategy for kidney cancer therapy
P478volume60

Reverse relations

Q41016076Downregulation of lncRNA SDPR-AS is associated with poor prognosis in renal cell carcinomacites workP2860

Search more.